会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method of producing .alpha.-L-aspartyl-L-phenylalanine methyl ester
hydrochloride
    • 生产α-L-天冬氨酰-L-苯丙氨酸甲酯盐酸盐的方法
    • US5225587A
    • 1993-07-06
    • US864133
    • 1992-04-06
    • Katsumi SugiyamaKiyo AdachiToshihide Yukawa
    • Katsumi SugiyamaKiyo AdachiToshihide Yukawa
    • C07K5/072C07K5/075
    • C07K5/0613
    • A method of purifying .alpha.-L-aspartyl-L-phenylalanine methyl ester as a hydrochloride salt thereof which comprises:i) contacting a mixture of .alpha.-L-aspartyl-L-phenylanaline methyl ester and .beta.-L-aspartyl-L-phenylalanine methyl ester with an aqueous medium containing (a) hydrogen chloride in an amount not more than ca. 2 mol., per liter of said aqueous medium, but not less than 1 mol., per mole of said of said mixture of .alpha.-L-aspartyl-L-phenylalanine methyl ester and .beta.-L-aspartyl-L-phenylalanine methyl ester, and (b) an inorganic chloride selected from the group consisting of NaCl, KCl, NH.sub.4 Cl, CaCl.sub.2, and ZnCl.sub.2 in an amount of at least ca. 50 g., per liter of said aqueous medium, to form crystals of .alpha.-L-aspartyl-L-phenylalanine methyl ester hydrochloride, andii) recovering the .alpha.-L-aspartyl-L-phenylalanine methyl ester hydrochloride crystals therefrom.
    • 纯化α-L-天冬氨酰基-L-苯丙氨酸甲酯盐酸盐的方法,其包括:i)使α-L-天冬氨酰基-L-苯亚胺甲酯与β-L-天冬氨酰基-L-苯丙氨酸的混合物 甲酯与含有(a)氯化氢的含水介质的量不大于约 每摩尔所述所述α-L-天冬氨酰基-L-苯丙氨酸甲酯和β-L-天冬氨酰-L-苯丙氨酸甲酯的混合物每升所述水性介质2摩尔,但不小于1摩尔 ,和(b)选自NaCl,KCl,NH 4 Cl,CaCl 2和ZnCl 2的无机氯化物,其量至少约为。 50升,每升所述水性介质中,形成α-L-天冬氨酰基-L-苯丙氨酸甲酯盐酸盐的晶体,和ii)从其中回收α-L-天冬氨酰基-L-苯丙氨酸甲酯盐酸盐晶体。
    • 6. 发明申请
    • Extract from plant of japanese parsley family and process for producing the same
    • 从日本欧芹系列植物提取物及其生产方法
    • US20070092587A1
    • 2007-04-26
    • US10561431
    • 2004-06-18
    • Hiromu OhnogiKatsumi SugiyamaNobuko MurakiTatsuji EnokiHiroaki SagawaIkunoshin Kato
    • Hiromu OhnogiKatsumi SugiyamaNobuko MurakiTatsuji EnokiHiroaki SagawaIkunoshin Kato
    • A61K36/232
    • A61K36/232A23L2/02A23V2002/00A23V2250/21A23V2200/328
    • The present invention provides an extract obtainable by extracting a plant belonging to Umbelliferae, or a processed product thereof, with a water-containing alcohol; a process for preparing the extract; a therapeutic agent or prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response and/or diabetic complications, characterized in that the therapeutic agent or prophylactic agent comprises as an effective ingredient the extract as defined above; an agent for an insulin-mimetic action, characterized in that the agent comprises as an effective ingredient the extract as defined above; a food, beverage or feed, comprising the extract as defined above; an agent for enhancing glucose uptake into a cell, characterized in that the agent comprises as an effective ingredient the extract as defined above; to an agent for inducing differentiation into an adipocyte, characterized in that the agent comprises as an effective ingredient the extract as defined above; and an inhibitory agent for aldose reductase, characterized in that the agent comprises as an effective ingredient the extract as define above.
    • 本发明提供通过用含水醇提取属于伞形赤霉属的植物或其加工产物而获得的提取物; 一种制备提取物的方法; 用于伴随胰岛素或胰岛素反应量和/或糖尿病并发症的异常的疾病的治疗剂或预防剂,其特征在于所述治疗剂或预防剂包含作为有效成分的上述提取物; 用于胰岛素模拟作用的药剂,其特征在于所述药剂包含如上所定义的提取物作为有效成分; 包含上述提取物的食品,饮料或饲料; 用于增强葡萄糖摄入细胞的药剂,其特征在于所述药剂包含如上所定义的提取物作为有效成分; 涉及诱导分化为脂肪细胞的药剂,其特征在于所述药剂包含如上所定义的提取物作为有效成分; 以及醛糖还原酶抑制剂,其特征在于,所述药剂含有作为有效成分的上述定义的提取物。